f-star, a Vienna, Austria-based antibody engineering company, has raised EUR6 million in Series A funding from Aescap Venture and Atlas Venture. F-star had previously raised EUR1.5 million in seed funding from Atlas, and another EUR3.5 million in loans and grants from Austrian government agencies. www.f-star.com
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
Copyright PEI Media
Not for publication, email or dissemination
Share with other subscribers
Only logged in subscribers of this site will be able to access the shared article.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.